melatonin has been researched along with cetrorelix in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ishii, H; Kato, M; Sakuma, Y; Sato, S; Yin, C | 1 |
| Alpini, G; DeMorrow, S; Giang, T; Glaser, S; Grant, S; Greene, JF; Jefferson, B; Kyritsi, K; McMillin, M; Meng, F; Venter, J; Wu, N; Zhou, T | 1 |
2 other study(ies) available for melatonin and cetrorelix
| Article | Year |
|---|---|
Cetrorelix, a gonadotropin-releasing hormone antagonist, induces the expression of melatonin receptor 1a in the gonadotropin-releasing hormone neuronal cell line GT1-7.
Topics: Animals; Cell Line; Cell Line, Tumor; Central Nervous System Depressants; Dose-Response Relationship, Drug; Gonadotropin-Releasing Hormone; Hormone Antagonists; Humans; Melatonin; Membrane Potentials; Mice; Neurons; NIH 3T3 Cells; Receptor, Melatonin, MT1; Receptor, Melatonin, MT2; Receptors, GABA-A; Receptors, LHRH; RNA, Messenger; Time Factors | 2009 |
Melatonin inhibits hypothalamic gonadotropin-releasing hormone release and reduces biliary hyperplasia and fibrosis in cholestatic rats.
Topics: Animals; Bile Ducts; Cell Proliferation; Central Nervous System Depressants; Cholestasis; Disease Models, Animal; Gonadotropin-Releasing Hormone; Hepatic Stellate Cells; Hormone Antagonists; Humans; Hyperplasia; Liver Cirrhosis; Melatonin; Pineal Gland; Rats; Receptors, LHRH | 2017 |